“They’re second-tier athletes who would like to be in the first tier.”

—H. Lee Sweeney, chairman of physiology at the Penn School of Medicine, on the athletes who e-mail him inquiring whether gene therapy could make them better. Gene therapy, some say, could becoming a new doping fad, but Sweeney and others warn the practice has its dangers.
(The Toronto Star, Jan. 16, 2005)

Originally published on January 27, 2005